Ketamine vs. SPRAVATO®: FDA Approval, Insurance & Clinical Fit
Both SPRAVATO® (esketamine) and ketamine target the brain's NMDA glutamate receptors to promote rapid neuroplasticity when traditional antidepressants fall short. At Attuned Psychiatry in Decatur, GA, board-certified psychiatrist Dr. Gideon Matzkin helps you compare FDA approval, in-network insurance coverage, dosing protocols, and safety so you can choose the right path forward.
SPRAVATO® (Esketamine) vs. Ketamine Therapy
An objective, psychiatrist-authored breakdown of molecular chemistry, FDA status, insurance eligibility, and in-clinic experience.
| Clinical Parameter | SPRAVATO® (Esketamine Nasal Spray) | Racemic Ketamine (IV / IM / Sublingual) |
|---|---|---|
| Active Molecule | Purified S-enantiomer (esketamine) with higher affinity for the NMDA receptor | 50/50 racemic mixture of R-ketamine and S-ketamine |
| FDA Approval Status | FDA-Approved for Treatment-Resistant Depression (TRD) & MDD with acute suicidal ideation | FDA-approved as an anesthetic; used off-label in psychiatry for depression and mood disorders |
| Insurance Coverage | Widely covered in-network (Aetna, Anthem BCBS, UHC/Optum, Cigna, TRICARE East) with Prior Authorization | Typically not covered by commercial insurance; offered via Self-Pay / Direct Care |
| Route of Administration | Self-administered nasal spray (no IV needles) under clinician supervision | Intravenous (IV) infusion, intramuscular (IM) injection, or sublingual lozenge |
| Safety & Observation | FDA REMS-certified 2-hour monitored observation with blood pressure & clinical checks | In-clinic medical monitoring during and after administration |
| Typical Induction Schedule | Twice weekly for 4 weeks, then weekly for 4 weeks, then individualized maintenance | Typically 6 induction sessions over 2–3 weeks, followed by maintenance boosters as needed |
Which Option Is Right for Your Care Plan?
During a comprehensive psychiatric evaluation with Dr. Gideon Matzkin, we review your diagnosis, medication history, and insurance benefits to recommend the safest, most accessible option.
When SPRAVATO® Is Often Preferred
- You have commercial insurance or TRICARE East and want in-network coverage with full Prior Authorization support
- You prefer a needle-free nasal spray with standardized, FDA-regulated dosing
- You have tried at least two prior antidepressants without sufficient relief (TRD)
- You want structured REMS clinical oversight in a calm, private Decatur suite
When Ketamine May Be Considered
- You do not meet narrow insurer prior-authorization criteria for SPRAVATO®
- You prefer a customized dosing protocol tailored to complex mood or trauma symptoms
- You are seeking a direct-care, physician-led alternative without insurer delays
- You want coordinated integration with ongoing psychiatric medication management or Deep TMS
Ketamine vs. SPRAVATO® FAQs
Can I switch from Ketamine to insurance-covered SPRAVATO®?
Yes. Many patients who initially paid out of pocket at standalone ketamine clinics transition to Attuned Psychiatry for FDA-approved SPRAVATO® once our team verifies their in-network benefits and secures prior authorization.
How does Attuned Psychiatry verify SPRAVATO® insurance benefits?
Our in-house team verifies your exact in-network medical and pharmacy benefits, checks deductible and out-of-pocket maximum status, and submits all clinical documentation for Prior Authorization (CPT/HCPCS G2082, G2083, and J0013) before your first session.
Can SPRAVATO® or Ketamine be combined with TMS?
Yes. Because Attuned Psychiatry offers BrainsWay Deep TMS™, NeuroStar® TMS, SPRAVATO®, ketamine, and psychiatric medication management under one roof, Dr. Matzkin can design a cohesive, multimodal plan when clinically appropriate.
Request Your Deep TMS Consultation
Take the first step toward sustained recovery. Our clinical intake coordinator will verify your insurance and contact you within one business day.